Articles with public access mandates - Dan Theodorescu MD, PhDLearn more
Not available anywhere: 5
Clinical opportunities and challenges in targeting tumour dormancy
JA Hensel, TW Flaig, D Theodorescu
Nature reviews Clinical oncology 10 (1), 41, 2013
Mandates: US National Institutes of Health
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma
M Frantzi, J Metzger, RE Banks, H Husi, J Klein, M Dakna, W Mullen, ...
Journal of proteomics 98, 44-58, 2014
Mandates: Cancer Research UK
Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer
B Ehdaie, GJ Stukenborg, D Theodorescu
The Journal of urology 182 (4), 1482-1487, 2009
Mandates: US National Institutes of Health
Predicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis
B Ehdaie, D Theodorescu
Expert review of anticancer therapy 8 (7), 1103-1110, 2008
Mandates: US National Institutes of Health
Re: Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status
TW Flaig, D Theodorescu
European urology 62 (1), 183, 2012
Mandates: US National Institutes of Health
Available somewhere: 161
Detection of circulating tumor DNA in early-and late-stage human malignancies
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
Mandates: US National Institutes of Health, Wellcome Trust, Government of Italy
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz Jr, ...
Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013
Mandates: US National Institutes of Health, Wellcome Trust
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Y Gui, G Guo, Y Huang, X Hu, A Tang, S Gao, R Wu, C Chen, X Li, L Zhou, ...
Nature genetics 43 (9), 875-878, 2011
Mandates: US National Institutes of Health
A community effort to assess and improve drug sensitivity prediction algorithms
JC Costello, LM Heiser, E Georgii, M Gönen, MP Menden, NJ Wang, ...
Nature biotechnology 32 (12), 1202-1212, 2014
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Academy …
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease
DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ...
Molecular & cellular proteomics 9 (11), 2424-2437, 2010
Mandates: US National Institutes of Health, National Institute of Health and Medical …
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
G Guo, X Sun, C Chen, S Wu, P Huang, Z Li, M Dean, Y Huang, W Jia, ...
Nature genetics 45 (12), 1459-1463, 2013
Mandates: US National Institutes of Health
The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations
Y Ru, KJ Kechris, B Tabakoff, P Hoffman, RA Radcliffe, R Bowler, ...
Nucleic acids research 42 (17), e133-e133, 2014
Mandates: US National Institutes of Health
Advances in bladder cancer biology and therapy
L Tran, JF Xiao, N Agarwal, JE Duex, D Theodorescu
Nature Reviews Cancer 21 (2), 104-121, 2021
Mandates: US National Institutes of Health
Metastasis: a therapeutic target for cancer
PS Steeg, D Theodorescu
Nature clinical practice Oncology 5 (4), 206-219, 2008
Mandates: US National Institutes of Health
TERT promoter mutations and telomerase reactivation in urothelial cancer
S Borah, L Xi, AJ Zaug, NM Powell, GM Dancik, SB Cohen, JC Costello, ...
Science 347 (6225), 1006-1010, 2015
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Recommendations for biomarker identification and qualification in clinical proteomics
H Mischak, G Allmaier, R Apweiler, T Attwood, M Baumann, A Benigni, ...
Science translational medicine 2 (46), 46ps42-46ps42, 2010
Mandates: US National Institutes of Health, British Heart Foundation
Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties
MS Ostenfeld, DK Jeppesen, JR Laurberg, AT Boysen, JB Bramsen, ...
Cancer research 74 (20), 5758-5771, 2014
Mandates: Danish Council for Independent Research
Isolation and identification of potential urinary microparticle biomarkers of bladder cancer
DM Smalley, NE Sheman, K Nelson, D Theodorescu
Journal of proteome research 7 (5), 2088-2096, 2008
Mandates: US National Institutes of Health
CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
JJ Coon, P Zürbig, M Dakna, AF Dominiczak, S Decramer, D Fliser, ...
Proteomics–Clinical Applications 2 (7‐8), 964-973, 2008
Mandates: US National Institutes of Health, British Heart Foundation
Adenosine A2B receptor blockade slows growth of bladder and breast tumors
C Cekic, D Sag, Y Li, D Theodorescu, RM Strieter, J Linden
The Journal of Immunology 188 (1), 198-205, 2012
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program